Clincosm LogoSign in Get a demo

Drug Administration From Enteral Nutrition Tube

Sponsor
Emel Külekçi (Other)
Overall Status
Completed
CT.gov ID
NCT05790291
Collaborator
(none)
69
Enrollment
1
Location
2
Arms
3
Actual Duration (Months)
22.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Enteral nutrition protocols are applied in patients who do not have gastrointestinal dysfunction but in whom oral feeding is contraindicated. In these patients, where drug use is also necessary but alternative drug administration routes are not possible, drugs can be given to the patient through enteral nutrition tubes. However, there are studies reporting errors and complications during drug administration from the enteral nutrition tube. With the planned thesis study, it is aimed to develop an evidence-based checklist and to reduce the rate of errors and complications in drug administration through enteral feeding tube with this checklist.

Condition or Disease Intervention/Treatment Phase
  • Other: Checklist
 N/A

Detailed Description

Enteral nutrition protocols are applied in patients who do not have gastrointestinal dysfunction but in whom oral feeding is contraindicated. In these patients, where drug use is also necessary but alternative drug administration routes are not possible, drugs can be given to the patient through enteral nutrition tubes.

When adding drugs to parenteral nutrition admixtures or using concomitant drugs from the same catheter, it has become a general rule to check for drug incompatibility. The same level of care is not taken in drug administration from the enteral nutrition tube. There are studies reporting errors and complications in enteral drug administration in the literature Today, one of the most important parts of corporate culture in healthcare is patient safety. Patient safety is all of the measures taken by health institutions and employees in these institutions in order to prevent the harm that health care services may cause to individuals. The main goal here is; It is the establishment of a system that will protect the patient from possible harm and eliminate the possibility of error due to errors that will prevent the occurrence of errors during care delivery.

The checklists used in recent years are also an evidence-based practice list and have become one of the effective methods used to prevent errors and reduce complications. A checklist standardizes the process, streamlines maintenance delivery, and improves performance to ensure all actions are covered. The checklist allows cross-checking what was done and in what order. These reassurances are important in situations where time is short and distractions.

With this study, it is aimed to develop an evidence-based checklist and to reduce the rate of errors and complications in drug administration through enteral feeding tube with this checklist.

Study Design

Study Type:
Interventional
Actual Enrollment :
69 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
randomized controlrandomized control
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
First, the participants were blinded. Participants were randomized after the pretest and divided into two groups. No explanation was given to the participants about how many groups there were and which group they belonged to. Second, the observer was blinded. Video recording was taken by the researcher during the administration in calculating the error rates. The video recordings were watched one by one by an assistant researcher who did not know the groups, and the administration steps were marked on the observation form as true/false. Third, the statistician was blinded.
Primary Purpose:
Prevention
Official Title:
The Effect Of The Check List Developed For Drug Administration From Enteral Nutrition Tube On Administration Errors
Actual Study Start Date :
Mar 15, 2022
Actual Primary Completion Date :
May 15, 2022
Actual Study Completion Date :
Jun 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: checklist

checklist

Other: Checklist
the experimental group will practice using the checklist
No Intervention: no intervention

no intervention

Outcome Measures

Primary Outcome Measures

  1. Change in enteral drug administration error rates of nurses with an interval of 2 months [baseline and month 2]

    First, the error rates of 69 nurses during enteral drug administration were calculated. Enteral medication was administered for approximately one month with the next intervention group (n=34) checklist. Finally, the error rates of 69 nurses during enteral drug administration were recalculated. Error rates were determined with a 19-item observation formula. Name of the form; Medication from Enteral Feeding Tube Observation Form for Applications The lowest error rate is 0%, the highest error rate is 100%.

Secondary Outcome Measures

  1. Change in enteral drug administration knowledge of nurses with an interval of 2 months [baseline and month 2]

    First, the knowledge levels of 69 nurses on enteral drug administration were calculated. Then the intervention group (n=34) administered enteral medication for approximately one month along with the checklist. Finally, the knowledge levels of 69 nurses on enteral drug administration were recalculated. Knowledge levels were determined with a 20-item information form. Name of the form; It is an Information Evaluation Form for Drug Administrations from Enteral Feeding Tube. The lowest score is 0, the highest score is 100.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  • Being an intensive care nurse

  • Have experience in administering enteral medication

  • Administering enteral medication to an adult patient

  • Agree to participate in the research

Exclusion Criteria:

  • Administering enteral medication to a patient with fluid restriction

  • Change of position

  • Wanting to leave research

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sağlık Bilimleri Üniversitesi Ankara Keçiören Turkey 06210

Sponsors and Collaborators

  • Emel Külekçi

Investigators

  • Principal Investigator: EMEL KÜLEKCİ, PhD student

Study Documents (Full-Text)

More Information

Additional Information:

Publications

Responsible Party:
Emel Külekçi, Lecturer, Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
ClinicalTrials.gov Identifier:
NCT05790291
Other Study ID Numbers:
  • 2021/29
First Posted:
Mar 30, 2023
Last Update Posted:
Mar 30, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Emel Külekçi, Lecturer, Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Enteral Tube
Enteral Drug Administration
Nurse
Medication Errors
Checklist

Study Results

No Results Posted as of Mar 30, 2023